Jyong Biotech Ltd.
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q2 25 | Q3 25 | Q4 25 | LTM* |
|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | |
| – | -6.4% | +0.0% | -14.2% | +0.0% | +171,395.3% | -99.9% | +199,900.0% | – | |
| – | -61.9% | +0.0% | +51.7% | +0.0% | – | – | – | – | |
| – | -43.7% | +0.0% | +16.2% | +0.0% | +147,592.3% | -99.9% | +199,900.0% | – | |
| – | – | – | – | – | – | – | – | – | |
| – | +28.5% | +202,614.9% | -99.9% | +200,241.3% | -29.0% | -99.8% | +276,202.1% | – | |
| – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.